240 related articles for article (PubMed ID: 20054104)
21. Immunogenicity of candidate DNA vaccine based on subtype A of human immunodeficiency virus type 1 predominant in Russia.
Murashev B; Kazennova E; Kozlov A; Murasheva I; Dukhovlinova E; Galachyants Y; Dorofeeva E; Dukhovlinov I; Smirnova G; Masharsky A; Klimov N; Kozlov AP
Biotechnol J; 2007 Jul; 2(7):871-8. PubMed ID: 17582822
[TBL] [Abstract][Full Text] [Related]
22. Expression and identification of immunological activities of the HIV-gp120N-human interferon gamma fusion protein.
Feng TT; Zhao G; Yao HP; Wang QP; Wu NP
Anat Rec (Hoboken); 2009 Mar; 292(3):381-6. PubMed ID: 19248157
[TBL] [Abstract][Full Text] [Related]
23. [Immune response induced by HIV DNA vaccine combined with recombinant adeno-associated virus].
Liu YZ; Zhou L; Wang Q; Ye SQ; Li HX; Zeng Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):251-4. PubMed ID: 15640860
[TBL] [Abstract][Full Text] [Related]
24. MVA-nef induces HIV-1-specific polyfunctional and proliferative T-cell responses revealed by the combination of short- and long-term immune assays.
Kutscher S; Allgayer S; Dembek CJ; Bogner JR; Protzer U; Goebel FD; Erfle V; Cosma A
Gene Ther; 2010 Nov; 17(11):1372-83. PubMed ID: 20535218
[TBL] [Abstract][Full Text] [Related]
25. Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery.
Bråve A; Ljungberg K; Boberg A; Rollman E; Isaguliants M; Lundgren B; Blomberg P; Hinkula J; Wahren B
Mol Ther; 2005 Dec; 12(6):1197-205. PubMed ID: 16112909
[TBL] [Abstract][Full Text] [Related]
26. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
27. Construction and immunogenicity of DNA vaccines encoding fusion protein of murine complement C3d-p28 and GP5 gene of porcine reproductive and respiratory syndrome virus.
Zhang D; Xia Q; Wu J; Liu D; Wang X; Niu Z
Vaccine; 2011 Jan; 29(4):629-35. PubMed ID: 21134449
[TBL] [Abstract][Full Text] [Related]
28. Clustered epitopes within the Gag-Pol fusion protein DNA vaccine enhance immune responses and protection against challenge with recombinant vaccinia viruses expressing HIV-1 Gag and Pol antigens.
Bolesta E; Gzyl J; Wierzbicki A; Kmieciak D; Kowalczyk A; Kaneko Y; Srinivasan A; Kozbor D
Virology; 2005 Feb; 332(2):467-79. PubMed ID: 15680412
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of immunogenicity and efficacy of combined DNA and adjuvanted protein vaccination in a human immunodeficiency virus type 1/murine leukemia virus pseudotype challenge model.
Rollman E; Mathy N; Bråve A; Boberg A; Kjerrström A; van Wely C; Engström G; Johansson S; Aperia K; Eriksson LE; Benthin R; Ertl P; Heeney J; Hinkula J; Voss G; Wahren B
Vaccine; 2007 Mar; 25(11):2145-54. PubMed ID: 17254672
[TBL] [Abstract][Full Text] [Related]
30. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine.
Takeda S; Shiosaki K; Kaneda Y; Nakasatomi T; Yoshizaki H; Someya K; Konno Y; Eda Y; Kino Y; Yamamoto N; Honda M
Clin Immunol; 2004 Jul; 112(1):92-105. PubMed ID: 15207786
[TBL] [Abstract][Full Text] [Related]
31. Designing and engineering of DNA-vaccine construction encoding multiple CTL-epitopes of major HIV-1 antigens.
Bazhan SI; Belavin PA; Seregin SV; Danilyuk NK; Babkina IN; Karpenko LI; Nekrasova NA; Lebedev LR; Ignatyev GM; Agafonov AP; Poryvaeva VA; Aborneva IV; Ilyichev AA
Vaccine; 2004 Apr; 22(13-14):1672-82. PubMed ID: 15068850
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of yellow fever virus 17D strain as a new vector for HIV-1 vaccine development.
Franco D; Li W; Qing F; Stoyanov CT; Moran T; Rice CM; Ho DD
Vaccine; 2010 Aug; 28(35):5676-85. PubMed ID: 20600494
[TBL] [Abstract][Full Text] [Related]
33. Engineering enhancement of the immune response to HBV DNA vaccine in mice by the use of LIGHT gene adjuvant.
Zhang Y; Jiang W; Fan Y; Wen J; Hao W; Qian M
J Virol Methods; 2008 Nov; 153(2):142-8. PubMed ID: 18722475
[TBL] [Abstract][Full Text] [Related]
34. Induction of human immunodeficiency virus type-1-specific immunity with a novel gene transport unit (GTU)-MultiHIV DNA vaccine.
Blazevic V; Männik A; Malm M; Sikut R; Valtavaara M; Toots U; Ustav M; Krohn K
AIDS Res Hum Retroviruses; 2006 Jul; 22(7):667-77. PubMed ID: 16831091
[TBL] [Abstract][Full Text] [Related]
35. Characterization of DNA and MVA vectors expressing Nef from HIV-1 CRF12_BF revealed high immune specificity with low cross-reactivity against subtype B.
Rodríguez AM; Turk G; Pascutti MF; Ferrer F; Nájera JL; Mónaco D; Esteban M; Salomón H; Calamante G; Gherardi MM
Virus Res; 2009 Dec; 146(1-2):1-12. PubMed ID: 19715734
[TBL] [Abstract][Full Text] [Related]
36. [Immunogenicity of a multiple epitope DNA vaccine against hepatitis B virus].
Luo LM; Li M; Xia H; Chen BH; Wang P; Hao WB
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 Sep; 20(5):517-21. PubMed ID: 15367337
[TBL] [Abstract][Full Text] [Related]
37. Naloxone/alum mixture a potent adjuvant for HIV-1 vaccine: induction of cellular and poly-isotypic humoral immune responses.
Velashjerdi Farahani S; Reza Aghasadeghi M; Memarnejadian A; Faezi S; Shahosseini Z; Mahdavi M
Pathog Glob Health; 2016 Mar; 110(2):39-47. PubMed ID: 26403975
[TBL] [Abstract][Full Text] [Related]
38. [Adjuvant effect of plasmid vector-expressed OX40L on candidate DNA vaccine against type B heptatitis].
Du X; Kang Y; Wang X; Wang J; Zhao G; Wang B
Wei Sheng Wu Xue Bao; 2009 Mar; 49(3):357-62. PubMed ID: 19623960
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of chloroplast-derived HIV-1 p24 and a p24-Nef fusion protein following subcutaneous and oral administration in mice.
Gonzalez-Rabade N; McGowan EG; Zhou F; McCabe MS; Bock R; Dix PJ; Gray JC; Ma JK
Plant Biotechnol J; 2011 Aug; 9(6):629-38. PubMed ID: 21443546
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 Gag p24-Nef fusion peptide induces cellular and humoral immune response in a mouse model.
Mahdavi M; Ebtekar M; Azadmanesh K; Khorramkhorshid HR; Rahbarizadeh F; Yazdi MH; Zabihollahi R; Abolhassani M; Hassan ZM
Acta Virol; 2010; 54(2):131-6. PubMed ID: 20545443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]